Why Is Xortx Therapeutics (XRTX) Stock Down 27% Today?


  • Xortx Therapeutics (XRTX) stock is falling after a recent rally.
  • The company’s shares soared roughly 100% on Friday.
  • However, the stock is retreating Monday after that climb.
XRTX Stock - Why Is Xortx Therapeutics (XRTX) Stock Down 27% Today?

Source: Shutterstock

Xortx Therapeutics (NASDAQ:XRTX) stock is sliding lower on Monday as the pharmaceutical company’s shares come off of a recent rally.

Shares of XRTX stock closed out normal trading hours on Friday up 100.6%. That massive boost in share price came alongside heavy trading, with some 91 million units changing hands. For comparison, the company’s daily average trading volume is about 1.6 million shares.

Considering that major rally, it makes sense that shares of XRTX stock would be down today. The inflated price was likely too much for the stock to maintain. Also, the company is unlikely to see that level of trading again today. In fact, trading volume is sitting at around 768,000 units as of this writing.

What’s Next for XRTX Stock?

XRTX stock could see additional movement this week as a special shareholder meeting is set for Friday. The company intends to seek approval from investors for a share consolidation plan. This would allow it to enact a reverse stock split of its shares.

Xortx Therapeutics is looking to use this reverse stock split as a way to increase the price of its shares. Even after its recent rally, the stock is still trading well below the $1 price point. That means it’s in danger of being delisted from the Nasdaq Exchange. A reverse stock split would solve that problem.

XRTX stock is down 27.3% as of Monday morning.

There’s even more stock market news traders will want to read about below!

We’ve got all of the hottest stock market news investors need to know about on Monday! That includes what’s going on with shares of Troika Media (NASDAQ:TRKA) stock, Akumin (NASDAQ:AKU) stock and LumiraDx (NASDAQ:LMDX) stock today. All of that news is available at the links below!

More Stock Market News for Monday

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risk.

Read More:Penny Stocks — How to Profit Without Getting Scammed

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Article printed from InvestorPlace Media, https://investorplace.com/2023/10/why-is-xortx-therapeutics-xrtx-stock-down-27-today/.

©2024 InvestorPlace Media, LLC